Current Concepts in Hematopathology

  • Continuing Education
image of blood cells.

-

Registration Deadline: May 12, 2027

Review key diagnostic challenges and emerging advances in clinical hematopathology, including myeloid and lymphoid diseases, classification updates, flow cytometry, molecular diagnostics, and the impact of novel therapeutics. Explore challenging cases through expert-led lectures, 12 case-based presentations, and interactive roundtable discussions.

  • Live Online

This course is taught online in real time.

 

 

Additionally, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.

For a full list of profession pricing see below.
View All

Continuing Education

Earn up to:
18.25 AMA PRA Category 1 Credits™
View All

 

All evaluations and credit claims must be completed within 60 days of the course end date.

3 Days

Please view the Schedule for a full description of the program.

On This Page

Overview

This course will provide pathologists with a review of diagnostic issues encountered in clinical hematopathology practice, with a focus on challenging cases, emerging entities, and technological advances.

The course will address:

  • Diagnosis of myeloid and lymphoid diseases, including incorporation of immunophenotypic and genetic data
  • Work-up of non-neoplastic lymph node and bone marrow
  • Forthcoming updates to the classification system
  • Modern approaches to flow cytometry and molecular diagnostics.

We will also address important subject matter not covered in the prior course (May 2022), including the impact of novel therapeutics on histologic interpretation and digital applications specific to hematopathology. Material will be presented as lectures by experts in hematopathology, as well as 12 case-based presentations and round tables with clinical and quality experts.

Learning Objectives

  • Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose and classify a broad range of lymph node and bone marrow pathologies.
  • Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms.
  • Diagnose challenging cases that do not readily conform to well-established entities.
  • Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy.

Developed and Offered By:

  • Brigham and Women's Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Brigham and Women's Hospital.

Who Should Participate

Specialty Physicians 

Schedule

All agenda sessions are in Eastern Time.

Day 1

Monday, May 12, 2025

Course Introduction

Elizabeth Morgan; Robert Hasserjian; Marian Harris

8:00-8:15 am

Nodal Small B-Cell Lymphomas

Elizabeth Morgan

8:15-9:00 am

Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma

Valentina Nardi

9:00-9:45 am

Question & Answer

Elizabeth Morgan; Valentina Nardi

9:45-10:00 am

Break

10:00-10:15 am

Immunodeficiency and Viral-Associated Lymphoproliferations

Judith Ferry

10:15-11:00 am

Updates in Cutaneous Lymphomas

Sam Sadigh

11:00-11:45 am

Question & Answer

Judith Ferry; Sam Sadigh

11:45 am-12:00 pm

Optional Workshop 1

12:00-12:30 pm

Cutaneous Lymphomas and Mimics: Clues to Diagnosis

Lyn Duncan

12:00-12:30 pm

Break

12:30-12:45 pm

Optional Workshop 2

12:45-1:15 pm

Cutaneous Lymphomas and Mimics: Clues to Diagnosis

Lyn Duncan

12:45-1:15 pm

Break

1:15-1:30 pm

Follicular Lymphoma and Related Entities

Abner Louissaint

1:30-2:15 pm

Diffuse Large B-Cell Lymphoma Subtypes

Scott B. Lovitch

2:15-3:00 pm

Question & Answer

Abner Louissaint; Scott B. Lovitch

3:00-3:15 pm

Break

3:15-3:30 pm

High-Grade B-Cell Lymphoma and Burkitt Lymphoma

Aliyah Sohani

3:30-4:15 pm

Reactive Lymphadenopathies and Castleman Disease

Yaso Natkunam

4:15-5:00 pm

Question & Answer

Yaso Natkunam; Aliyah Sohani

5:00-5:15 pm

Optional Workshop 3

5:15-5:45 pm

Extranodal Lymphomas

Judith Ferry

5:15-5:45 pm

Break

5:45-6:00 pm

Optional Workshop 4

6:00-6:30 pm

Extranodal Lymphomas

Judith Ferry

6:00-6:30 pm

Day 2

Tuesday, May 13, 2025

Approach to Peripheral Smear Review

Elizabeth Courville

8:15-9:00 am

Myelodysplastic Syndrome and Its Differential Diagnosis

Robert Hasserjian

9:00-9:45 am

Question & Answer

Elizabeth Courville; Robert Hasserjian

9:45-10:00 am

Break

10:00-10:15 am

Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage

Olga Weinberg

10:15-11:00 am

Acute Lymphoblastic Leukemia

Marian Harris

11:00-11:45 am

Question & Answer

Olga Weinberg; Marian Harris

11:45 am-12:00 pm

Optional Workshop 1

12:00-12:30 pm

Surgical Pathology Mimics of Hematopoietic Neoplasms

Jason Hornick

12:00-12:30 pm

Break

12:30-12:45 pm

Optional Workshop 2

12:45-1:15 pm

Surgical Pathology Mimics of Hematopoietic Neoplasms

Jason Hornick

12:45-1:15 pm

Break

1:15-1:30 pm

Eosinophilias and Mast Cell Disorders

Olga Pozdnyakova

1:30-2:15 pm

Myelodysplastic/Myeloproliferative Neoplasms

Robert Hasserjian

2:15-3:00 pm

Question & Answer

Olga Pozdnyakova; Robert Hasserjian

3:00-3:15 pm

Break

3:15-3:30 pm

Interpreting Minimal Residual Disease Panels in Flow Cytometry

Sa Wang

3:30-4:15 pm

Practical Interpretation of Molecular Testing in Myeloid Neoplasms

Annette Kim

4:15-5:00 pm

Question & Answer

Sa Wang; Annette Kim

5:00-5:15 pm

Optional Workshop 3

5:15-5:45 pm

Chronic Myeloid Neoplasms

Robert Hasserjian

5:15-5:45 pm

Break

5:45-6:00 pm

Optional Workshop 4

6:00-6:30 pm

Chronic Myeloid Neoplasms

Robert Hasserjian

6:00-6:30 pm

Day 3

Wednesday, May 14, 2025

Challenges in the Diagnosis of Hodgkin Lymphomas

Marian Harris

8:15-9:00 am

Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas

Scott Rodig

9:00-9:45 am

Question & Answer

Marian Harris; Scott Rodig

9:45-10:00 am

Break

10:00-10:15 am

Indolent T-Cell Disorders

Kathleen Burns

10:15-11:00 am

Nodal T-Cell Lymphomas

Roberto Chiarle

11:00-11:45 am

Question & Answer

Kathleen Burns; Roberto Chiarle

11:45 am-12:00 pm

Optional Workshop 1

12:00-12:30 pm

Acute Leukemias

Jon Aster

12:00-12:30 pm

Break

12:30-12:45 pm

Optional Workshop 2

12:45-1:15 pm

Acute Leukemias

Jon Aster

12:45-1:15 pm

Break

1:15-1:30 pm

Histiocytic and Dendritic Cell Neoplasms

Elizabeth Morgan

1:30-2:00 pm

IgG4-Related Disease and Lymphadenopathy

Jacob Bledsoe

2:00-2:30 pm

Blastic Plasmacytoid Dendritic Cell Neoplasm

Gabriel Griffin

2:30-3:00 pm

Question & Answer

Jacob Bledsoe; Gabriel Griffin

3:00-3:15 pm

Break

3:15-3:30 pm

Myeloid Neoplasms with Germline Predisposition

Mark Fleming

3:30-4:00 pm

Spleen Pathology

Lawrence Zukerberg

4:00-4:30 pm

Question & Answer

Lawrence Zukerberg; Mark Fleming

4:30-5:00 pm

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Andrew Allbee, MD, PhD
Instructor in Pathology, Harvard Medical School

Jon C. Aster, MD, PhD
Ramzi S. Cotran Professor of Pathology, Harvard Medical School

Jacob R. Bledsoe, MD
Assistant Professor of Pathology, Harvard Medical School

Katelyn Dannheim, MD
Assistant Professor of Pathology, Harvard Medical School

Megan J. Fitzpatrick, MD
Instructor in Pathology, Harvard Medical School

Mark D. Fleming, MD, DPhil
S. Burt Wolbach Professor of Pathology, Harvard Medical School
Pathologist-In-Chief, Boston Children's Hospital

Gabriel K. Griffin, MD
Assistant Professor of Pathology, Harvard Medical School

Bartosz Grzywacz, MD
Member of the Faculty of Pathology, Harvard Medical School

Raavi Gupta, MBBS
Member of the Faculty of Pathology, Harvard Medical School

Marian H. Harris, MD, PhD
Assistant Professor of Pathology, Harvard Medical School

Yael K. Heher, MD, MPH
Associate Professor of Pathology, Harvard Medical School

Christopher B. Hergott, MD, PhD
Instructor in Pathology, Harvard Medical School

Kirill Karlin, MD
Instructor in Pathology, Harvard Medical School

Habibe Kurt, MD
Instructor in Pathology, Harvard Medical School

Ann S. LaCasce, MD
Associate Professor of Medicine, Harvard Medical School

Abner Louissaint Jr., MD, PhD
Associate Professor of Medicine, Harvard Medical School

Marlise R. Luskin, MD
Associate Professor of Medicine, Harvard Medical School

Phillip D. Michaels, MD
Associate Professor of Medicine, Harvard Medical School

Valentina Nardi, MD
Associate Professor of Pathology, Harvard Medical School

Sarah Ondrejka, DO
Associate Professor, Cleveland Clinic Lerner College of Medicine / Case Western Reserve University

Stefania Pittaluga, MD, PhD
Senior Research Physician, Laboratory of Pathology, National Cancer Institute

Scott J. Rodig, MD, PhD
Professor of Pathology, Harvard Medical School

Sam Sadigh, MD
Assistant Professor of Pathology, Harvard Medical School

Andras Schaffer, MD, PhD
Member of the Faculty of Pathology, Harvard Medical School

Jansen N. Seheult, MB, BCh, BAO, MD 
Assistant Professor of Laboratory Medicine and Pathology, Mayo Clinic

Vignesh Shanmugam, MD
Instructor in Pathology, Harvard Medical School

Akiko Shimamura, MD, PhD
Professor of Pediatrics, Harvard Medical School

Aliyah R. Sohani, MD
Professor of Pathology, Harvard Medical School

Miekan Stonhill, MD
Instructor in Pathology, Harvard Medical School

Harrison K. Tsai, MD, PhD
Assistant Professor of Pathology, Harvard Medical School 

Brianna Waller, MD
Instructor in Pathology, Harvard Medical School

Sarah J. Wu, MD, PhD
Instructor in Pathology, Harvard Medical School

Complete Your Registration

Started a registration? Log in to enroll today.

Log in to Access.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, and most recordings will be available 60 days after the course ends. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Review the cancellation policy.

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

In Person, Hybrid, or Live Online (Virtual) accredited activities: These activities are accredited as Live or Blended/Other activities. To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

Online; Self Paced (On Demand) accredited activities: These activities are accredited as Enduring activities for three years. To receive CME/CE credit, learners must pass the course post-test and complete the course evaluation in order to claim credit before the final day of the accreditation period. Learners have access to the course for 60 days after the accreditation period has expired.

The Harvard Medical School designates this other/blended activity for a maximum of 18.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Medical Knowledge
  • Practice-Based Learning and Improvement
  • Systems-Based Practice

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Specialties